This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lophius Biosciences Gmbh. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Kristina Naumann: Innovator in T Cell Detection Technology
Introduction
Kristina Naumann is a prominent inventor based in Amberg, Germany. She has made significant contributions to the field of immunology, particularly in the detection and quantification of T cell populations. Her innovative work has led to the development of a patented method that enhances the understanding of immune responses.
Latest Patents
Kristina Naumann holds a patent for a method titled "Method for detection, differentiation and quantification of T cell populations by way of reverse transcription quantitative real time PCR (RT-qPCR) technology." This invention involves a series of steps that include contacting a body fluid with antigens, incubating the sample, and using RT-qPCR technology to detect and quantify specific T cell populations. The method provides a valuable tool for researchers and clinicians in the field of immunology.
Career Highlights
Naumann is currently associated with Lophius Biosciences GmbH, where she continues to advance her research in T cell detection. Her work is instrumental in developing diagnostic tools that can improve patient outcomes in various medical conditions.
Collaborations
Some of her notable coworkers include Ludwig Deml and Kornelia Schlombs, who contribute to the collaborative efforts at Lophius Biosciences GmbH. Their teamwork fosters an environment of innovation and scientific discovery.
Conclusion
Kristina Naumann's contributions to T cell detection technology exemplify the impact of innovative research in immunology. Her patented method represents a significant advancement in the field, showcasing her dedication to improving diagnostic capabilities.